Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Yamaoka, Masakazu Kita, Tadashi Kodama, N. Sawai, Jiro Imanishi (1996)
Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.Gastroenterology, 110 6
Xue-jun Fan, H. Gunasena, Zhi-qing Cheng, R. Espejo, S. Crowe, P. Ernst, V. Reyes (2000)
Helicobacter pylori Urease Binds to Class II MHC on Gastric Epithelial Cells and Induces Their Apoptosis1The Journal of Immunology, 165
J. Rudi, D. Kuck, S. Strand, S. Strand, A. Herbay, S. Mariani, P. Krammer, P. Galle, P. Galle, W. Stremmel (1998)
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.The Journal of clinical investigation, 102 8
N. Salama, G. Otto, L. Tompkins, S. Falkow (2001)
Vacuolating Cytotoxin of Helicobacter pylori Plays a Role during Colonization in a Mouse Model of InfectionInfection and Immunity, 69
P. Unge (2003)
Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 582
André Blum, Nicholas Talley, C. O'Morain, S. Zanten, J. Labenz, M. Stolte, J. Louw, Arild Stubberöd, Á. Theodórs, M. Sundin, E. Bolling-Sternevald, O. Junghard (1998)
Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer DyspepsiaThe New England Journal of Medicine, 339
F. Perri, V. Festa, R. Clemente, M. Villani, M. Quitadamo, N. Caruso, M. Bergoli, A. Andriulli (2001)
Randomized study of two “rescue” therapies for helicobacter pylori-infected patients after failure of standard triple therapiesAmerican Journal of Gastroenterology, 96
T. Blanchard, S. Czinn (2000)
Immunology of Helicobacter pylori and prospects for vaccine.Gastroenterology clinics of North America, 29 3
S. Keates, A. Keates, M. Warny, R. Peek, P. Murray, C. Kelly (1999)
Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori.Journal of immunology, 163 10
P. Malfertheiner, E. Bayerdörffer, U. Diete, J. Gil, T. Lind, P. Misiuna, C. O'Morain, P. Sipponen, R. Spiller, J. Stasiewicz, H. Treichel, L. Újszászy, P. Unge, S. Zanten, L. Zeijlon (1999)
The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcerAlimentary Pharmacology & Therapeutics, 13
L. Smythies, K. Waites, J. Lindsey, P. Harris, P. Ghiara, Phillip Smith (2000)
Helicobacter pylori-Induced Mucosal Inflammation Is Th1 Mediated and Exacerbated in IL-4, But Not IFN-γ, Gene-Deficient Mice1The Journal of Immunology, 165
T. Lind, F. Mégraud, P. Unge, E. Bayerdörffer, C. O'Morain, R. Spiller, S. Zanten, K. Bardhan, M. Hellblom, M. Wrangstadh, L. Zeijlon, C. Cederberg (1999)
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.Gastroenterology, 116 2
K. Goodman, P. Correa, Heraldo Aux, Hemán Ramirez, J. DeLany, Oscar Pepinosa, Mercedes Quiñones, Tito Parra (1996)
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways.American journal of epidemiology, 144 3
C. Goodwin, JA Strong (1986)
Campylobacter pyloridis, gastritis, and peptic ulceration.Journal of Clinical Pathology, 39
M. Dore, A. Sepulveda, H. El-Zimaity, Y. Yamaoka, M. Osato, Kato Mototsugu, A. Nieddu, G. Realdi, D. Graham (2001)
Isolation of helicobacter pylori from sheep—implications for transmission to humansAmerican Journal of Gastroenterology, 96
H. Malaty, D. Graham (1994)
Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection.Gut, 35
J. Sung, F. Chan, Justin Wu, W. Leung, R. Suen, T. Ling, Y. Lee, A. Cheng, S. Chung (1999)
One‐week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC‐MACH studyAlimentary Pharmacology & Therapeutics, 13
Alter Mj, Coleman Pj, Alexander Wj, Choo Ql, G. Kuo, Weiner Aj, Overby Lr, Bradley Dw, Houghton M, Garson Ja, Tedder Rs, Briggs M, D. Forman, D. Newell, F. Fullerton, G. Yarnell, A. Stacey, N. Wald, F. Sitas (1991)
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.British Medical Journal, 302
Gisbert, González, Calvet, Roqué, Gabriel, Pajares (2000)
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacyAlimentary Pharmacology & Therapeutics, 14
M. Tufano, Fabio Rossano, P. Catalanotti, Giorgio Liguori, C. Capasso, Ceccarelli Mt, P. Marinelli (1994)
Immunobiological activities of Helicobacter pylori porinsInfection and Immunity, 62
R. Alm, L. Ling, D. Moir, B. King, E. Brown, P. Doig, Douglas Smith, B. Noonan, B. Guild, B. Dejonge, G. Carmel, P. Tummino, A. Caruso, M. Uría-Nickelsen, D. Mills, C. Ives, R. Gibson, D. Merberg, S. Mills, Q. Jiang, Diane Taylor, G. Vovis, T. Trust (1999)
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pyloriNature, 397
Jide Wang, E. Brooks, K. Bamford, T. Denning, J. Pappo, P. Ernst (2001)
Negative Selection of T Cells by Helicobacter pylori as a Model for Bacterial Strain Selection by Immune Evasion1The Journal of Immunology, 167
B. Drumm, S. Koletzko, G. Oderda (2000)
helicobacter pylori Infection in Children: A Consensus StatementJournal of Pediatric Gastroenterology and Nutrition, 30
S. Suerbaum, John Smith, K. Bapumia, G. Morelli, N. Smith, E. Kunstmann, I. Dyrek, M. Achtman (1998)
Free recombination within Helicobacter pylori.Proceedings of the National Academy of Sciences of the United States of America, 95 21
L. Handt, J. Fox, F. Dewhirst, G. Fraser, B. Paster, Lili Yan, H. Rozmiarek, R. Rufo, I. Stalis (1994)
Helicobacter pylori isolated from the domestic cat: public health implicationsInfection and Immunity, 62
M. Dixon (2001)
Pathology of Gastritis and Peptic Ulceration
A. Neubauer, C. Thiede, B. Alpen, M. Ritter, B. Neubauer, G. Ehninger, A. Morgner, E. Bayerdörffer, T. Wündisch, M. Stolte (1997)
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.Journal of the National Cancer Institute, 89 18
J. Parsonnet, G. Friedman, D. Vandersteen, Yuan Chang, J. Vogelman, N. Orentreich, R. Sibley (1991)
Helicobacter pylori infection and the risk of gastric carcinoma.The New England journal of medicine, 325 16
S. Odenbreit, J. Püls, Bettina Sedlmaier, Elke Gerland, W. Fischer, R. Haas (2000)
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.Science, 287 5457
D. Falush, C. Kraft, N. Taylor, P. Correa, J. Fox, M. Achtman, S. Suerbaum (2001)
Recombination and mutation during long-term gastric colonization by Helicobacter pylori: Estimates of clock rates, recombination size, and minimal ageProceedings of the National Academy of Sciences of the United States of America, 98
Houben, D. Beek, Hensen, A. Craen, Rauws, Tytgat (1999)
A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 13
E. El-Omar, M. Carrington, W. Chow, K. McColl, J. Bream, H. Young, Jesus Herrera, J. Lissowska, Chiu-Chin Yuan, N. Rothman, G. Lanyon, Maureen Martin, J. Fraumeni, C. Rabkin (2000)
Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 404
W. Peterson, AA Ciociola, D. Sykes, DJ McSorley, DD Webb (1996)
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group [see comments]Alimentary Pharmacology & Therapeutics, 10
Q. Zhang, M. Nakshabendi, J. Dawodu, R. Gemmell, Russell Departments, B. Zhang, I. Nakshabendi, M. Mokhashi, R. Russell (1996)
Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.Gut, 38
A. Nomura, G. Stemmermann, P. Chyou, I. Kato, G. Perez-Perez, M. Blaser (1991)
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.The New England journal of medicine, 325 16
W. Schwizer, M. Thumshirn, J. Dent, I. Guldenschuh, D. Menne, G. Cathomas, M. Fried (2001)
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trialThe Lancet, 357
F. Catalano, G. Branciforte, R. Catanzaro, C. Bentivegna, R. Cipolla, G. Nuciforo, A. Brogna (1999)
Comparative Treatment of Helicobacter pylori–Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple TherapyHelicobacter, 4
N. Uemura, T. Mukai, S. Okamoto, S. Yamaguchi, Hiroto Mashiba, K. Taniyama, N. Sasaki, K. Haruma, K. Sumii, G. Kajiyama (1997)
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 6 8
(1961)
Initial manag ement strategies for dyspepsia
Y. Tindberg, M. Blennow, M. Granström (1999)
Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infectionActa Pædiatrica, 88
T. Lind, S. Zanten, P. Unge, R. Spiller, E. Bayerdörffer, C. O'Morain, K. Bardhan, M. Bradette, N. Chiba, M. Wrangstadh, C. Cederberg, J. Idström (1996)
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1
H. Miwa, R. Ohkura, T. Murai, Kenji Sato, A. Nagahara, S. Hirai, Sumio Watanabe, N. Sato (1999)
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection—comparison with omeprazole and lansoprazoleAlimentary Pharmacology & Therapeutics, 13
(1999)
Erratum Nature
J. Fox, T. Wang (2001)
Helicobacter pylori--not a good bug after allThe New England journal of medicine, 345 11
J. Misiewicz, A. Harris, K. Bardhan, S. Levi, C. O'Morain, Boris OGUIBENINE, G. Kerr, M. Dixon, H. Langworthy, D. Piper (1997)
One week triple therapy for Helicobacter pylori: a multicentre comparative studyGut, 41
K. Nagata, Eriko Takagi, Toshihide Tamura (1995)
[Helicobacter pylori urease].Nihon saikingaku zasshi. Japanese journal of bacteriology, 50 4
Toshihiko Tomita, Andrew Jackson, N. Hida, Mumtaz Hayat, M. Dixon, Takashi Shimoyama, A. Axon, Philip Robinson, J. Crabtree (2001)
Expression of Interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection.The Journal of infectious diseases, 183 4
Meining, Kiel, Stolte (1998)
Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer diseaseAlimentary Pharmacology & Therapeutics, 12
J. Guruge, Per Falk, Robin Lorenz, Maria Dans, Hans-Peter Wirth, Martin Blaser, D. Berg, Jeffrey Gordon (1998)
Epithelial attachment alters the outcome of Helicobacter pylori infection.Proceedings of the National Academy of Sciences of the United States of America, 95 7
JC Atherton, R. Peek, KT Tham, T. Cover, M. Blaser (1997)
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori.Gastroenterology, 112 1
K. Mccoll, L. Murray, E. El-Omar, A. Dickson, A. El-Nujumi, A. Wirz, A. Kelman, Christine Penny, R. Knill-Jones, T. Hilditch (1998)
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.The New England journal of medicine, 339 26
(2001)
Helicobacter motility and chemotaxis
D. Weeks, Sepehr Eskandari, David Scott, George Sachs (2000)
A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization.Science, 287 5452
L. Coelho, R. León-Barúa, E. Quigley (2000)
Latin-American Consensus Conference on Helicobacter pylori infectionAmerican Journal of Gastroenterology, 95
(2001)
Epidemiologic observations and open que stions about disease and infection caused by Helicobacter pylori
J. Crabtree, J. Wyatt, L. Trejdosiewicz, P. Peichl, P. Nichols, N. Ramsay, J. Primrose, I. Lindley (1994)
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.Journal of Clinical Pathology, 47
(2000)
A dy namic transmission model for predicting trends in Helicobacter pylori and as sociated diseases in the United States
A. Wotherspoon (1998)
Helicobacter pylori infection and gastric lymphoma.British medical bulletin, 54 1
F. Mégraud, S. Hazell, Youri Glupczynski (2001)
Antibiotic susceptibility and resistance
R. Schlemper, S. Werf, I. Biemond, C. Lamers (1996)
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer diseaseEuropean Journal of Gastroenterology & Hepatology, 8
H. Higashi, Ryouhei Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, M. Hatakeyama (2001)
SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA ProteinScience, 295
U. Mai, G. Perez-Perez, J. Allen, S. Wahl, M. Blaser, Phillip Smith (1992)
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosaThe Journal of Experimental Medicine, 175
F. Bazzoli (2001)
Key points from the revised Maastricht Consensus Report: the impact on general practice.European journal of gastroenterology & hepatology, 13 Suppl 2
B. Marshall, J. Warren, E. Blincow, M. Phillips, C. Goodwin, R. Murray, StephenJ. Blackbourn, ThomasE. Waters, C. Sanderson (1988)
PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 332
J. Fox (1998)
Helicobacter species and in vivo models of gastrointestinal cancerAlimentary Pharmacology & Therapeutics, 12
M. Sato (2001)
Pooled Analysis on the Efficacy of the Second-line Treatment Regimens for Helicobacter pylori InfectionScandinavian Journal of Gastroenterology, 36
D. Ilver, A. Arnqvist, Johan Ögren, I. Frick, D. Kersulyte, E. Incecik, D. Berg, A. Covacci, L. Engstrand, T. Borén (1998)
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.Science, 279 5349
A. Blum, N. Talley, C. O'Morain, S. Zanten, Joachim Labenz, M. Stolte, J. Louw, A. Stubberöd, Á. Theodórs, M. Sundin, E. Bolling-Sternevald, O. Junghard (1998)
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.The New England journal of medicine, 339 26
S. Zanten, Bradette, Farley, Leddin, Lind, Unge, Bayerdörffer, Spiller, O’morain, Sipponen, Wrangstadh, Zeijlon, Sinclair (1999)
The DU‐MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapyAlimentary Pharmacology & Therapeutics, 13
J. Parsonnet, H. Shmuely, T. Haggerty (1999)
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.JAMA, 282 23
M. Naumann, S. Wessler, C. Bartsch, B. Wieland, A. Covacci, R. Haas, T. Meyer (1999)
Activation of Activator Protein 1 and Stress Response Kinases in Epithelial Cells Colonized by Helicobacter pylori Encoding the cag Pathogenicity Island*The Journal of Biological Chemistry, 274
N. Banatvala, K. Mayo, F. Mégraud, R. Jennings, J. Deeks, R. Feldman (1993)
The cohort effect and Helicobacter pylori.The Journal of infectious diseases, 168 1
Mobley Hlt, Mendz Gl, S. Hazell (2001)
Pathology of Gastritis and Peptic Ulceration -- Helicobacter pylori: Physiology and Genetics
M. Dore, G. Leandro, G. Realdi, A. Sepulveda, D. Graham (2004)
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori TherapyDigestive Diseases and Sciences, 45
R. Laheij, L. Rossum, J. Jansen, H. Straatman, A. Verbeek (1999)
Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysisAlimentary Pharmacology & Therapeutics, 13
F. Perri, M. Villani, M. Quitadamo, V. Annese, G. Niro, A. Andriulli (2001)
Ranitidine bismuth citrate‐based triple therapies after failure of the standard ‘Maastricht triple therapy’: a promising alternative to the quadruple therapy?Alimentary Pharmacology & Therapeutics, 15
C. Howden, R. Hunt (1998)
Guidelines for the management of Helicobacter pylori infectionAmerican Journal of Gastroenterology, 93
G. Perez-Perez, B. Dworkin, J. Chodos, M. Blaser (1988)
Campylobacter pylori antibodies in humans.Annals of internal medicine, 109 1
E. Bayerdörffer, B. Rudolph, A. Neubauer, C. Thiede, N. Lehn, S. Eidt, M. Stolte, Malt Group (1995)
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 345
L. Laine, Brian Fennerty, M. Osato, J. Sugg, L. Suchower, P. Probst, J. Levine (2000)
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trialsAmerican Journal of Gastroenterology, 95
Marianne Lee, J. Kemp, Adrianne Canning, C. Egan, G. Tataronis, F. Farraye (1999)
A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.Archives of internal medicine, 159 19
P. Moayyedi, Chandu Bardhan, Lynne Young, M. Dixon, Lorna Brown, A. Axon (2001)
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.Gastroenterology, 121 5
S. Lam, N. Talley (1998)
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infectionJournal of Gastroenterology and Hepatology, 13
C. Howden, G. Leontiadis (2000)
Extragastric manifestations of Helicobacter pylori — are they relevant?
Hongxiang Liu, Agnes Ruskon-Fourmestraux, A. Lavergne‐Slove, H. Ye, T. Molina, Y. Bouhnik, R. Hamoudi, T. Diss, A. Doğan, F. Mégraud, J. Rambaud, M. Du, P. Isaacson (2001)
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapyThe Lancet, 357
Joette Meyer, N. Silliman, Wenjin Wang, N. Siepman, J. Sugg, David Morris, Jie Zhang, H. Bhattacharyya, Eileen King, R. Hopkins (2002)
Recovery Rate and Prognosis in Older Persons Who Develop Acute Lung Injury and the Acute Respiratory Distress SyndromeAnnals of Internal Medicine, 136
Mobley Hlt, Mendz Gl, S. Hazell (2001)
Antibiotic Susceptibility and Resistance -- Helicobacter pylori: Physiology and Genetics
Calvet, García, López, Gisbert, Gené, Roqué (2000)
A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 14
M. Floch (2001)
Helicobacter pylori: Molecular and Cellular BiologyJournal of Clinical Gastroenterology, 33
I. Szabó, S. Brutsche, F. Tombola, M. Moschioni, B. Satin, J. Telford, R. Rappuoli, C. Montecucco, E. Papini, M. Zoratti (1999)
Formation of anion‐selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activityThe EMBO Journal, 18
J. Solnick, D. Schauer (2001)
Emergence of Diverse HelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic DiseasesClinical Microbiology Reviews, 14
R. Negrini, A. Savio, B. Appelmelk (1997)
Autoantibodies to Gastric Mucosa in Helicobacter pylori InfectionHelicobacter, 2
J. Crabtree, T. Shallcross, R. Heatley, J. Wyatt (1991)
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.Gut, 32
W. Fischer, J. Püls, Renate Buhrdorf, B. Gebert, S. Odenbreit, R. Haas (2001)
Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8Molecular Microbiology, 42
J. Parsonnet, S. Hansen, Larissa Rodriguez, A. Gelb, R. Warnke, E. Jellum, N. Orentreich, J. Vogelman, G. Friedman (1994)
Helicobacter pylori infection and gastric lymphoma.The New England journal of medicine, 330 18
E. Segal, J. Cha, J. Lo, S. Falkow, L. Tompkins (1999)
Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori.Proceedings of the National Academy of Sciences of the United States of America, 96 25
P. Michetti, C. Kreiss, K. Kotloff, N. Porta, J. Blanco, D. Bachmann, Maribelle Herranz, P. Saldinger, I. Corthésy-Theulaz, G. Losonsky, R. Nichols, J. Simon, M. Stolte, Samuel Ackerman, T. Monath, A. Blum (1999)
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.Gastroenterology, 116 4
Y. Yamaoka, M. Kita, T. Kodama, N. Sawai, K. Kashima, J. Imanishi (1997)
Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strainsGut, 41
S. Censini, C. Lange, Z. Xiang, J. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, A. Covacci (1996)
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.Proceedings of the National Academy of Sciences of the United States of America, 93 25
Naomi Uemura, Sumika Okamoto, S. Yamamoto, Nobuyuki Matsumura, Shigeki Yamaguchi, Michio Yamakido, Kiyomi Taniyama, Noboyuki Sasaki, R. Schlemper (2001)
Helicobacter pylori infection and the development of gastric cancer.The New England journal of medicine, 345 11
J. Tomb, O. White, A. Kerlavage, R. Clayton, G. Sutton, R. Fleischmann, K. Ketchum, H. Klenk, S. Gill, B. Dougherty, K. Nelson, J. Quackenbush, Lixin Zhou, E. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. Khalak, A. Glodek, K. Mckenney, L. Fitzegerald, N. Lee, M. Adams, E. Hickey, D. Berg, Jeanine Gocayne, T. Utterback, J. Peterson, J. Kelley, M. Cotton, Janice Weidman, C. Fujii, C. Bowman, Larry Watthey, E. Wallin, W. Hayes, M. Borodovsky, P. Karp, Hamilton Smith, C. Fraser, J. Venter (1997)
The complete genome sequence of the gastric pathogen Helicobacter pyloriNature, 388
D. Evans, D. Evans, T. Takemura, Hironobu Nakano, H. Lampert, D. Graham, D. Granger, P. Kvietys (1995)
Characterization of a Helicobacter pylori neutrophil-activating proteinInfection and Immunity, 63
M. Rowland, Deepak Kumar, L. Daly, P. O'connor, D. Vaughan, B. Drumm (1999)
Low rates of Helicobacter pylori reinfection in children.Gastroenterology, 117 2
P. Harris, L. Smythies, Phillip Smith, Andre Dubois (2000)
Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates.The Journal of infectious diseases, 181 2
A. Galmiche, J. Rassow, A. Doye, S. Cagnol, J. Chambard, S. Contamin, Virginie Thillot, I. Just, V. Ricci, E. Solcia, Ellen Obberghen, P. Boquet (2000)
The N‐terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c releaseThe EMBO Journal, 19
Akira Terano (1999)
[Asia Pacific Consensus Conference on the management of Helicobacter pylori].Nihon rinsho. Japanese journal of clinical medicine, 57 1
C. Dooley, H. Cohen, P. Fitzgibbons, M. Bauer, M. Appleman, G. Perez-Perez, M. Blaser (1989)
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.The New England journal of medicine, 321 23
A. Morgner, N. Lehn, L. Andersen, C. Thiede, M. Bennedsen, K. Trebesius, B. Neubauer, A. Neubauer, M. Stolte, E. Bayerdörffer (2000)
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.Gastroenterology, 118 5
Mobley Hlt, Mendz Gl, S. Hazell (2001)
Markers of Infection -- Helicobacter pylori: Physiology and Genetics
H. pylori is one of the most common bacterial infections in human beings, and its discovery 20 years ago altered the diagnosis and treatment of gastroduodenal disease. This review considers current knowledge about the epidemiology and transmission of H. pylori, as well as the role of this infectious agent in the pathogenesis of upper gastrointestinal tract disease. Diagnostic approaches, indications for therapy, and measures of therapeutic efficacy are reviewed.
The New England Journal of Medicine – The New England Journal of Medicine
Published: Oct 10, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.